Boxwood Ventures’s Pfizer PFE Stock Holding History

Boxwood Ventures’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$469K	Hold	19,248	–	–	0.28%	29
2026 Q1	$540K	Hold	19,248	–	–	0.57%	25
2025 Q4	$479K	Hold	19,248	–	–	0.48%	26
2025 Q3	$490K	Buy	+19,248	New	+$475K	0.55%	25

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Boxwood Ventures's PFE Position: Q2 2026 in Review

Boxwood Ventures held its Pfizer (PFE) position steady in Q2 2026 at 19,248 shares worth $469K. The position accounts for 0.28% of the portfolio, ranked #29.

Boxwood Ventures first reported a position in PFE in Q3 2025 and has held it in 4 quarters since. The position peaked at $540K in Q1 2026. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Boxwood Ventures held 19,248 shares of Pfizer worth $469K as of Q2 2026.
Boxwood Ventures left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.28% of Boxwood Ventures's portfolio in Q2 2026, its #29 holding.
Boxwood Ventures first reported a position in Pfizer in Q3 2025 and has held it in 4 quarters since.
Boxwood Ventures's Pfizer position peaked at $540K in Q1 2026.
2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Boxwood Ventures's 13F filing for Q2 2026, filed 12 Aug 2026.